Cubist Systematic Strategies, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.3 - $3.58 $1.83 Million - $5.03 Million	1,404,928 New	1,404,928 $3.37 Million
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $372,820 - $605,183	173,405 Added 2928.15%	179,327 $410,000
Q1 2023 May 15, 2023	SELL	$1.99 - $2.68 $24,522 - $33,025	-12,323 Reduced 67.54%	5,922 $14,000
Q4 2022 Feb 14, 2023	SELL	$1.8 - $2.56 $8,280 - $11,776	-4,600 Reduced 20.14%	18,245 $34,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $44,319 - $78,358	22,845 New	22,845 $55,000
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $14,168 - $29,095	-10,816 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $109,184 - $217,808	-55,992 Reduced 83.81%	10,816 $23,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $84,597 - $136,776	22,204 Added 49.78%	66,808 $263,000
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $150,761 - $238,631	44,604 New	44,604 $215,000
Q2 2021 Aug 16, 2021	SELL	$4.12 - $5.87 $53,325 - $75,975	-12,943 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.45 - $9.09 $110,758 - $291,825	-32,104 Reduced 71.27%	12,943 $76,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $3.67 $47,299 - $165,322	45,047 New	45,047 $154,000
Q4 2019 Feb 14, 2020	SELL	$3.16 - $5.15 $135,497 - $220,826	-42,879 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.2 - $6.66 $51,454 - $285,574	42,879 New	42,879 $129,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $111,429 - $148,087	-20,828 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $44,280 - $80,638	10,156 Added 95.16%	20,828 $116,000
Q4 2018 Feb 14, 2019	SELL	$6.15 - $10.51 $41,205 - $70,417	-6,700 Reduced 38.57%	10,672 $71,000
Q3 2018 Nov 14, 2018	SELL	$10.32 - $13.06 $113,860 - $144,090	-11,033 Reduced 38.84%	17,372 $185,000
Q2 2018 Aug 14, 2018	BUY	$7.8 - $13.69 $18,509 - $32,486	2,373 Added 9.12%	28,405 $341,000
Q1 2018 May 15, 2018	BUY	$7.86 - $11.39 $35,912 - $52,040	4,569 Added 21.29%	26,032 $223,000
Q4 2017 Feb 14, 2018	BUY	$8.77 - $12.28 $81,745 - $114,461	9,321 Added 76.77%	21,463 $212,000
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $147,768 - $197,914	12,142	12,142 $149,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $143M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account